We have also shown that citrullinated peptides from PPAD are a target of the ACPA response in a subset of patients with RA [10], though it remains unclear whether this response is driven by citrullination of PPAD [14] or whether it is part of a polyreactive ACPA response. The gene discussed is PRTN3; the disease is rheumatoid arthritis.